Skip to main content
Insights
/ Webinars

Activating Open Innovation, with LEO Pharma

LEO Pharma
Thu, Apr 03, 2025
16:00 CET | 10:00 EST
Activating Open Innovation, with LEO Pharma

Reserve your seat

First name
Last name
Business email
Company name
Job title
Which sector best reflects your role?
By submitting this form, you agree to receive email communications from Inpart as well as the storing and processing of your personal data by Inpart as detailed in the Privacy Statement. You may unsubscribe from these communications at any time.

How do Open Innovation teams source the best science?

Finding the perfect partner, project, or asset in the global web of science is no easy feat. Drawing on their experiences and the success of a recent search campaign with Inpart (which generated a record-breaking 162 submissions from academic institutes and biotech companies!), experts from LEO Pharma will join us for a discussion on best practices in Open Innovation.

Panelists

Dr. Lars Erik Vølund Kristensen
Dr. Lars Erik Vølund Kristensen
Vice President, Head of External Innovation — LEO Pharma
Ferda Cevikbas
Ferda Cevikbas
Vice President, Head of Science — LEO Pharma

Further information

Inpart’s Activating Open Innovation series invites industry leaders to present their external partnering initiatives, creating a forum for exchange across the scientific community, with the aim of equipping researchers and scientific decision-makers with the means to deliver high-impact science through strategic partnerships and alliances.

LEO Pharma are a research-based pharmaceutical company and a global leader in dermatology. Headquartered in Denmark, LEO’s Open Innovation teamdrive the discovery and development of treatments for the increasing number of people living with skin diseases globally, proactively scouting for new approaches to address skin conditions with unmet medical needs and burden of disease.